Paracetamol Versus Ibuprofen for PDA Closure
NCT03265782 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-08-29
Summary
Comparison between the safety and efficacy of oral paracetamol and oral ibuprofen in treatment of Patent Ductus Arteriosus (PDA) in premature infants
Conditions
- Patent Ductus Arteriosus
Interventions
- DRUG
-
drug was adminstred with a loading dose 10 mg/kg/day followed by 5 mg/kg/day in 2 doses with 24 hrs apart for 3 days
- DRUG
-
drug was administred for 3 consequetive days in a dosev 15 mg/kg/dose every 6 hrs and follow up echo was done after 3 days
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 28 Weeks
- Max Age
- 35 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-09-30
- Completion
- 2018-01-31
More Related Trials
-
Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
NCT02002741 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
NCT01544972 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates
NCT06601114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
NCT01261117 ·Status: COMPLETED ·Phase: NA
-
Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
NCT04397913 ·Status: UNKNOWN
-
Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
NCT07338370 ·Status: RECRUITING
-
Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus
NCT04037514 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
NCT03103022 ·Status: COMPLETED ·Phase: PHASE1
-
Addition of Acetaminophen in Standard PDA Management
NCT04026464 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
NCT00642330 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants
NCT05493540 ·Status: COMPLETED ·Phase: PHASE2
-
Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants
NCT01755728 ·Status: COMPLETED ·Phase: PHASE3
-
Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
NCT00485160 ·Status: COMPLETED ·Phase: PHASE3
-
IV Acetaminophen and Patent Ductus Arteriosus
NCT03008876 ·Status: COMPLETED ·Phase: NA
-
Paracetamol Treatment of the Borderline Significant PDA
NCT02819414 ·Status: UNKNOWN ·Phase: PHASE2
-
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus
NCT03648437 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
NCT01149564 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
NCT01511887 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
NCT03701074 ·Status: TERMINATED ·Phase: PHASE2
-
No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
NCT02128191 ·Status: COMPLETED ·Phase: PHASE2
-
The Preterm Infants' Paracetamol Study
NCT01938261 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
NCT01243996 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Acetaminophen vs Indomethacin in Treating hsPDA
NCT03537144 ·Status: TERMINATED ·Phase: PHASE3
-
Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
NCT00961753 ·Status: TERMINATED ·Phase: PHASE4
-
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
NCT00833365 ·Status: TERMINATED ·Phase: NA